Pilot Intervention for PTSD, Nonadherence, and HIV Risk
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stress Disorders, Post-Traumatic
- Sponsor
- Kent State University
- Enrollment
- 70
- Locations
- 2
- Primary Endpoint
- PTSD symptoms
- Last Updated
- 17 years ago
Overview
Brief Summary
The primary aim of this project is to examine the efficacy of prolonged exposure (PE) therapy at reducing HIV-related PTSD symptoms, increasing adherence to antiretroviral medication regimens, and increasing health-related quality of life (QOL) in HIV+ patients.
Detailed Description
HIV+ patients will be randomized to receive either PE therapy (up to 18 possible sessions) or weekly symptom monitoring (described below) and will complete measures of PTSD, adherence, and QOL pre- and post-intervention and at 3- and 6-month follow-up assessments. Secondary analyses will examine the impact of the intervention on disorders commonly comorbid with PTSD (i.e., anxiety, mood, and substance abuse/dependence disorders).
Investigators
Eligibility Criteria
Inclusion Criteria
- •Must be HIV+
- •Must meet PTSD diagnostic criteria
- •Must be taking HIV medications
- •Must be able to read and write in English
Exclusion Criteria
- •Current or previous diagnosis of schizophrenia, any current diagnosis with psychotic features, or current suicidal ideation
- •Being in a current abusive relationship or ongoing intimate relationship with one's assailant
- •Mental retardation
Outcomes
Primary Outcomes
PTSD symptoms
Time Frame: pre- & post-intervention, 3-month post, & 6-month post
Secondary Outcomes
- Adherence to HIV medications(pre- & post-intervention, 3-month post, & 6-month post)
- Health-related Quality of Life(pre- & post-intervention, 3-month post, & 6-month post)